Literature DB >> 31157682

Thromboelastometry in critically ill patients with disseminated intravascular coagulation.

Marcella C A Müller1, Joost C Meijers2,3, David M van Meenen1, Jecko Thachil4, Nicole P Juffermans1.   

Abstract

: Coagulopathy has a high incidence in critically ill patients and is often caused by disseminated intravascular coagulation (DIC). Although the clinical picture of DIC ranges from a prothrombotic state to severe consumption coagulopathy with an increased bleeding tendency, there are no clinical tests that reflect of in-vivo hemostatic profile. Rotational thromboelastometry (ROTEM) may be able to indicate whether a patient has a hypocoagulable or hypercoagulable profile and possibly be able to discriminate patients with and without DIC. The aim of this article was to study the diagnostic ability of thromboelastometry to detect DIC. A predefined subgroup analysis of a clinical trial in critically ill patients with a coagulopathy was done. ROTEM and markers of coagulation and levels of natural anticoagulants were measured in patients with and without DIC. Twenty-three patients were included, 13 fulfilled criteria for overt DIC. Patients with DIC had lower platelet count, lower levels of fibrinogen, factors II, VII and VIII compared with those without DIC. Antithrombin, protein C and S were also reduced in DIC patients. Receiver operator characteristic analyses showed that EXTEM CFT, alpha angle and MCF were capable of discriminating patients with and without DIC. Combination of ROTEM values with protein C or antithrombin further improved discriminatory ability. In patients with DIC, thromboelastometry profiles were more hypocoagulable compared with those without DIC. ROTEM correlates well with ISTH DIC score, diagnostic strength improves when ROTEM values are combined with antithrombin or protein C levels. Thereby, ROTEM may be a useful tool in diagnosing DIC in the critically ill.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31157682     DOI: 10.1097/MBC.0000000000000808

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  6 in total

1.  Clinical Validation of Global Coagulation Tests to Guide Blood Component Transfusions in Cirrhosis and ACLF.

Authors:  Madhumita Premkumar; Rohit Mehtani; Smita Divyaveer; Kamal Kajal; Anand V Kulkarni; Syed Ahmed; Harmanpreet Kaur; Harpreet Kaur; Radhakrishna Dhiman; Ajay Duseja; Arka De
Journal:  J Clin Transl Hepatol       Date:  2021-02-18

2.  Induced normothermia ameliorates the procoagulant host response in human endotoxaemia.

Authors:  Matthew B A Harmon; Nanon F L Heijnen; Sanne de Bruin; Niek H Sperna Weiland; Joost C M Meijers; Anita M de Boer; Marcus J Schultz; Janneke Horn; Nicole P Juffermans
Journal:  Br J Anaesth       Date:  2021-04-23       Impact factor: 9.166

3.  Coagulation profile in severe COVID-19 patients: what do we know so far?

Authors:  Felicio Savioli; Leonardo Lima Rocha
Journal:  Rev Bras Ter Intensiva       Date:  2020-06-24

4.  Application of Rotational Thromboelastometry in Patients with Acute Promyelocytic Leukemia.

Authors:  Nikica Sabljic; Nikola Pantic; Marijana Virijevic; Zoran Bukumiric; Tina Novakovic; Zlatko Pravdic; Jovan Rajic; Ana Vidovic; Nada Suvajdzic; Mark Jaradeh; Jawed Fareed; Darko Antic; Mirjana Mitrovic
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

5.  Thromboelastography Parameters as Predictors for Long-Term Survival in Critically Ill Patients.

Authors:  Cuizhu Luo; Bingjie Zhuang; Zhongqing Chen
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

Review 6.  Disseminated intravascular coagulation: A devastating systemic disorder of special concern with COVID-19.

Authors:  Parmvir Singh; Robert A Schwartz
Journal:  Dermatol Ther       Date:  2020-09-04       Impact factor: 3.858

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.